6.60Open6.60Pre Close0 Volume2 Open Interest10.00Strike Price0.00Turnover368.79%IV-4.29%PremiumJul 19, 2024Expiry Date6.74Intrinsic Value100Multiplier7DDays to Expiry0.00Extrinsic Value100Contract SizeAmericanOptions Type-0.9733Delta0.0423Gamma0.48Leverage Ratio-0.0054Theta-0.0009Rho-0.47Eff Leverage0.0003Vega
CureVac Stock Discussion
Benzinga· 1 min ago
New trial date for U.S. patent litigation set for March 3, 2025, following settlement with Acuitas Therapeutics.
First instance decision on validity of EP 3 708 668 B1 (split poly-A tail technology) scheduled for March 25, 2025, by European Patent Office in the context of the German patent liti...
loading...
No comment yet